Editas Medicine, Inc. (EDIT)

Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	123.65	141.52	203.52	139.68	238.18
Short-Term Investments	199.46	202.75	296.33	262.43	218.96
Cash & Cash Equivalents	323.11	344.27	499.85	402.11	457.14
Cash Growth	-6.15%	-31.12%	24.31%	-12.04%	23.90%
Receivables	10.19	5.15	0.27	6.05	0.42
Other Current Assets	7.53	7.34	7.2	10.93	6.29
Total Current Assets	340.83	356.75	507.31	419.09	463.84
Property, Plant & Equipment	45.71	59.22	43.29	39.15	39.65
Long-Term Investments	104.02	93.1	120.07	109.66	0
Other Long-Term Assets	8.59	5.25	6.81	4.7	5.39
Total Long-Term Assets	158.32	157.57	170.17	153.52	45.04
Total Assets	499.15	514.32	677.48	572.6	508.89
Accounts Payable	8.27	9.51	5.05	6.41	5.84
Deferred Revenue	68.89	68.89	72.22	94.93	186.72
Current Debt	12.16	11.08	10.31	6.81	5.8
Other Current Liabilities	-26.1	-29.37	-40.7	-49.94	-138.41
Total Current Liabilities	63.22	60.11	46.88	58.21	59.96
Long-Term Debt	24.37	32.86	16.07	19.32	23.28
Other Long-Term Liabilities	62.47	60.67	60.89	101.48	163.21
Total Long-Term Liabilities	86.84	93.53	76.96	120.81	186.49
Total Liabilities	150.06	153.64	123.84	179.02	246.45
Total Debt	36.54	43.95	26.38	26.14	29.08
Debt Growth	-16.86%	66.60%	0.93%	-10.13%	-10.29%
Retained Earnings	-1,231.35	-1,078.13	-857.7	-665.2	-549.22
Comprehensive Income	0.2	-3.6	-0.49	-0.05	0.11
Shareholders' Equity	349.1	360.68	553.64	393.59	262.44
Net Cash / Debt	286.58	300.33	473.47	375.98	428.06
Net Cash / Debt Growth	-4.58%	-36.57%	25.93%	-12.17%	27.19%
Net Cash Per Share	3.77	4.37	7.00	6.41	8.56
Working Capital	277.61	296.64	460.43	360.88	403.88
Book Value Per Share	4.59	5.25	8.19	6.71	5.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).